Furthermore, it has been reported that in the treatment of myocardial infarction, the therapeutic effect is improved when CD18 is overexpressed in transplanted adipose-derived stem cells [45], indicating that CD18 on transplanted cells is also important in the treatment of myocardial infarction. This evidence concerns the gene ITGB2 and myocardial infarction.